Disease / condition

Dry Age-related Macular Degeneration clinical trials

Free access to 19 studies·9+ countries·Updated daily7 recruiting
19
Total trials
9+
Countries
10+
Sponsors
7
Recruiting
By phase
N/A8
Phase 25
Early Phase 12
Phase 12
Phase 1/21
By status
Recruiting7
Completed5
Active, not rec...2
Not yet recruit...2
Unknown2
Top countries
United States of America7
China3
Australia,France,Germany,Spain,United Kingdom,United States of America2
Canada1
France1
Top sponsors
LumiThera, Inc.4
Gyroscope Therapeu...2
Chinese Academy of...2
Pixium Vision SA2
Optimal Acuity Cor...1
Recent trials
Latest clinical trials for Dry Age-related Macular Degeneration
NCT06351605Recruiting
A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT)
LumiThera, Inc.Norway
NCT06229665·Phase 2/3Recruiting
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)
LumiThera, Inc.United States of America
NCT05706896Recruiting
Atrophic Age-related Macular Degeneration (AMD) Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma (CB-PRP): a Pilot Study
Fondazione Policlinico Univers...Italy
NCT05536752·Phase 2Recruiting
QA102 Phase II Study in Subjects With Dry AMD
Smilebiotek Zhuhai LimitedUnited States of America
NCT04627428·Phase 1/2Not yet recr...
Safety and Tolerability of RPESC-derived RPE Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)
Luxa Biotechnology, LLCUnited States of America
NCT04566445·Phase 2Recruiting
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Gyroscope Therapeutics LimitedAustralia,France,Germany,Spain,United Kingdom,United States of America
NCT04511936Withdrawn
Microcurrent Stimulation for Dry Age-related Macular Degeneration
i-Lumen Scientific, Inc.
NCT04437368·Phase 2Recruiting
EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Gyroscope Therapeutics LimitedAustralia,France,Germany,Spain,United Kingdom,United States of America
NCT04349254Completed
Observational Study of Vision Improvement in Late Stage Dry AMD Patients
Optimal Acuity CorporationCanada
NCT04065490Not yet recr...
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)
LumiThera, Inc.United States of America
NCT03878420Completed
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II)
LumiThera, Inc.France,Germany,Italy,Spain,United Kingdom
NCT03626636·Phase 2Completed
A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration
Allegro Ophthalmics, LLCUnited States of America
NCT03392324Active, not ...
PRIMA US-Feasibility Study in Atrophic Dry AMD
Pixium Vision SAUnited States of America
NCT03333954Active, not ...
Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration
Pixium Vision SAFrance
NCT03144999·Phase 1Completed
Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59
Janssen Research & Development...United States of America
NCT03046407·Early Phase 1
Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells
Chinese Academy of SciencesChina
NCT02755428·Early Phase 1
Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases
Chinese Academy of SciencesChina
ChiCTR-OPC-15006757·Phase 1Recruiting
Untitled Trial
The First Affiliated Hospital ...China
NCT01379560·Phase 2Completed
A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration
Sucampo Pharma Americas, LLCAustria
About this record

Access comprehensive clinical trial information for Dry Age-related Macular Degeneration through Pure Global AI's free database. This collection includes 19 clinical trials across multiple phases including N/A, Phase 2, Early Phase 1. Currently, 7 trials are actively recruiting participants.

Research for Dry Age-related Macular Degeneration is being conducted in United States of America, China, Australia,France,Germany,Spain,United Kingdom,United States of America and 6+ other countries. Leading sponsors include LumiThera, Inc. and Gyroscope Therapeutics Limited. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 19 clinical trials studying Dry Age-related Macular Degeneration, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 9+ countries.

Top research sponsors include LumiThera, Inc., Gyroscope Therapeutics Limited, Chinese Academy of Sciences, among others.